TM TradeMark: Measurement of Anaesthesia-depth Trough Narcotrend TM in Patients Undergoing Electro-Convulsion-Therapy (ECT)- Influence of Anasthesia Depth on Quality of Convulsion

Sponsor
Medical University Innsbruck (Other)
Overall Status
Completed
CT.gov ID
NCT03897985
Collaborator
(none)
15
1
9.4
1.6

Study Details

Study Description

Brief Summary

The Electro-Convulsion-Therapy (ECT) is a well accepted treatment option in severe depression. The quality of ECT is evaluated basing on minimal seizure duration (>15sec), the sympathic response and the postictal EEG-suppression.

For the treatment general anaesthesia is needed. On the other hand anaesthesia strongly influences the quality of the seizure. The goal is to find an anaesthesia-depth that is needed for the well-being of the patient and allows a good ECT.

In daily routine the dose of anesthetic agents and the assesment of anesthesia-depth is based on the subjective estimation of the anesthetist and also on ealier interventions.

The aim of the study is to assess any correlation between measured anesthesia-depth using the Narcotrend TM and the Quality of the ECT.

Condition or Disease Intervention/Treatment Phase
  • Device: Narcotrend TM

Study Design

Study Type:
Observational
Actual Enrollment :
15 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Measurement of Anaesthesia-depth Trough Narcotrend TM in Patients Undergoing Electro-Convulsion-Therapy (ECT)- Influence of Anaesthesia Depth on Quality of Convulsion - A Non-Intervention Trial
Actual Study Start Date :
May 1, 2019
Actual Primary Completion Date :
Feb 12, 2020
Actual Study Completion Date :
Feb 12, 2020

Outcome Measures

Primary Outcome Measures

  1. Correlation of anesthesia depth measured by Narcotrend TM and quality of ECT treatment [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • ASA (American Society of Anesthesiologists) Physical Satus I-3

  • 18 years < 90 years

  • Signed informed consent

Exclusion Criteria:
  • Refusal of the patient

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University Innsbruck Innsbruck Austria

Sponsors and Collaborators

  • Medical University Innsbruck

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University Innsbruck
ClinicalTrials.gov Identifier:
NCT03897985
Other Study ID Numbers:
  • Narcotrend-ECT Study
First Posted:
Apr 1, 2019
Last Update Posted:
Sep 3, 2020
Last Verified:
Mar 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 3, 2020